Drug
elacestrant
Marketed as ORSERDU.
Generic name
elacestrant
Brand names
ORSERDU
First FDA approval
2023-01-27
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA217639 | ORSERDU | 2023-01-27 | STEMLINE THERAP |
Manufacturers
STEMLINE THERAP
Frequently asked questions
When was elacestrant FDA approved?
Earliest FDA approval on record: 2023-01-27.
What brand names are sold as elacestrant?
ORSERDU.
Sources
Appeal a elacestrant denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com